Acetylation and nuclear receptor action

Journal of Steroid Biochemistry and Molecular Biology

Volumn 123, Issue 3-5, 2011, Pages 91-100

  Wang, Chenguang ^a   Tian, Lifeng ^b   Popov, Vladimir M ^b   Pestell, Richard G ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Acetylation; Nuclear receptor action

Indexed keywords

ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; FARNESOID X RECEPTOR; GLUCOCORTICOID RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 4; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; LIVER X RECEPTOR; RETINOID X RECEPTOR; SIRTUIN; STEROIDOGENIC FACTOR 1; THYROID HORMONE RECEPTOR;

ACETYLATION; ARTICLE; CANCER GROWTH; CARCINOGENESIS; DNA BINDING; HUMAN; LIGAND BINDING; METABOLIC DISORDER; PHYLOGENY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

EID: 79151474217     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.12.003     Document Type: Review

References (90)

1. D.J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R.M. Evans The nuclear receptor superfamily: the second decade Cell 83 1995 835 839
2. N. Novac, and T. Heinzel Nuclear receptors: overview and classification Curr. Drug Targets Inflamm. Allergy 3 2004 335 346
3. W.B. Pratt, and D.O. Toft Steroid receptor interactions with heat shock protein and immunophilin chaperones Endocr. Rev. 18 1997 306 360
4. J.C. Blanco, S. Minucci, J. Lu, X.J. Yang, K.K. Walker, H. Chen, R.M. Evans, Y. Nakatani, and K. Ozato The histone acetylase PCAF is a nuclear receptor coactivator Genes Dev. 12 1998 1638 1651
5. J. Xu, R.C. Wu, and B.W. O'Malley Normal and cancer-related functions of the p160 steroid receptor coactivator (SRC) family Nat. Rev. Cancer 9 2009 615 630
6. V.M. Popov, J. Zhou, L.A. Shirley, J. Quong, W.S. Yeow, J.A. Wright, K. Wu, H. Rui, R.K. Vadlamudi, J. Jiang, R. Kumar, C. Wang, and R.G. Pestell The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling Cancer Res. 69 2009 5752 5760
7. M. Fu, C. Wang, A.T. Reutens, J. Wang, R.H. Angeletti, L. Siconolfi-Baez, V. Ogryzko, M.L. Avantaggiati, and R.G. Pestell p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation J. Biol. Chem. 275 2000 20853 20860
8. C. Wang, M. Fu, R.H. Angeletti, L. Siconolfi-Baez, A.T. Reutens, C. Albanese, M.P. Lisanti, B.S. Katzenellenbogen, S. Kato, T. Hopp, S.A. Fuqua, G.N. Lopez, P.J. Kushner, and R.G. Pestell Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity J. Biol. Chem. 276 2001 18375 18383
9. A. Sanchez-Pacheco, O. Martinez-Iglesias, M. Mendez-Pertuz, and A. Aranda Residues K128, 132, and 134 in the thyroid hormone receptor-alpha are essential for receptor acetylation and activity Endocrinology 150 2009 5143 5152
10. H.Y. Lin, R. Hopkins, H.J. Cao, H.Y. Tang, C. Alexander, F.B. Davis, and P.J. Davis Acetylation of nuclear hormone receptor superfamily members: thyroid hormone causes acetylation of its own receptor by a mitogen-activated protein kinase-dependent mechanism Steroids 70 2005 444 449
11. X. Li, S. Zhang, G. Blander, J.G. Tse, M. Krieger, and L. Guarente SIRT1 deacetylates and positively regulates the nuclear receptor LXR Mol. Cell 28 2007 91 106
12. S. Fang, S. Tsang, R. Jones, B. Ponugoti, H. Yoon, S.Y. Wu, C.M. Chiang, T.M. Willson, and J.K. Kemper The p300 acetylase is critical for ligand-activated farnesoid X receptor (FXR) induction of SHP J. Biol. Chem. 283 2008 35086 35095
13. J.K. Kemper, Z. Xiao, B. Ponugoti, J. Miao, S. Fang, D. Kanamaluru, S. Tsang, S.Y. Wu, C.M. Chiang, and T.D. Veenstra FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states Cell Metab. 10 2009 392 404
14. E. Soutoglou, N. Katrakili, and I. Talianidis Acetylation regulates transcription factor activity at multiple levels Mol. Cell 5 2000 745 751
15. W.X. Zhao, M. Tian, B.X. Zhao, G.D. Li, B. Liu, Y.Y. Zhan, H.Z. Chen, and Q. Wu Orphan receptor TR3 attenuates the p300-induced acetylation of retinoid X receptor-alpha Mol. Endocrinol. 21 2007 2877 2889
16. M.Y. Kim, E.M. Woo, Y.T.E. Chong, D.R. Homenko, and W.L. Kraus Acetylation of estrogen receptor a by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor Mol. Endocrinol. 20 2006 1479 1493
17. K. Ito, S. Yamamura, S. Essilfie-Quaye, B. Cosio, M. Ito, P.J. Barnes, and I.M. Adcock Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression J. Exp. Med. 203 2006 7 13
18. L. Gaughan, I.R. Logan, S. Cook, D.E. Neal, and C.N. Robson Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor J. Biol. Chem. 277 2002 25904 25913
19. W.Y. Chen, L.J. Juan, and B.C. Chung SF-1 (nuclear receptor 5A1) activity is activated by cyclic AMP via p300-mediated recruitment to active foci, acetylation, and increased DNA binding Mol. Cell. Biol. 25 2005 10442 10453
20. A.L. Jacob, J. Lund, P. Martinez, and L. Hedin Acetylation of steroidogenic factor 1 protein regulates its transcriptional activity and recruits the coactivator GCN5 J. Biol. Chem. 276 2001 37659 37664
21. H. Endoh, K. Maruyama, Y. Masuhiro, Y. Kobayashi, M. Goto, H. Tai, J. Yanagisawa, D. Metzger, S. Hashimoto, and S. Kato Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha Mol. Cell. Biol. 19 1999 5363 5372
22. J.G. Greger, N. Fursov, N. Cooch, S. McLarney, L.P. Freedman, D.P. Edwards, and B.J. Cheskis Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase Mol. Cell. Biol. 27 2007 1904 1913
23. Y. Kobayashi, T. Kitamoto, Y. Masuhiro, M. Watanabe, T. Kase, D. Metzger, J. Yanagisawa, and S. Kato p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor and by interacting directly with the N-terminal A/B domains J. Biol. Chem. 2000 15645 15651
24. D.P. Edwards The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors J. Mammary Gland Biol. Neoplasia 5 2000 307 324
25. T. Ratajczak Protein coregulators that mediate estrogen receptor function Reprod. Fertil. Dev. 13 2001 221 229
26. Y. Cui, M. Zhang, R. Pestell, E.M. Curran, W.V. Welshons, and S.A. Fuqua Phosphorylation of estrogen receptor alpha blocks its acetylation and regulates estrogen sensitivity Cancer Res. 64 2004 9199 9208
27. Y. Cui, A. Niu, R. Pestell, R. Kumar, E.M. Curran, Y. Liu, and S.A. Fuqua Metastasis-associated protein 2 is a repressor of estrogen receptor {alpha} whose overexpression leads to estrogen-independent growth of human breast cancer cells Mol. Endocrinol. 2006
28. Y. Ma, S. Fan, C. Hu, Q. Meng, S.A. Fuqua, R.G. Pestell, Y.A. Tomita, and E.M. Rosen BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha Mol. Endocrinol. 24 2010 76 90
29. I. Barone, Y. Cui, M.H. Herynk, A. Corona-Rodriguez, C. Giordano, J. Selever, A. Beyer, S. Ando, and S.A. Fuqua Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway Cancer Res. 69 2009 4724 4732
30. Z. Culig, B. Comuzzi, H. Steiner, G. Bartsch, and A. Hobisch Expression and function of androgen receptor coactivators in prostate cancer J. Steroid Biochem. Mol. Biol. 92 2004 265 271
31. L. Wang, C.L. Hsu, and C. Chang Androgen receptor corepressors: an overview Prostate 63 2005 117 130
32. M. Fu, M. Liu, A.A. Sauve, X. Jiao, X. Zhang, X. Wu, M.J. Powell, T. Yang, W. Gu, M.L. Avantaggiati, N. Pattabiraman, T.G. Pestell, F. Wang, A.A. Quong, C. Wang, and R.G. Pestell Hormonal control of androgen receptor function through SIRT1 Mol. Cell. Biol. 26 2006 8122 8135
33. K. Wu, S. Katiyar, A. Witkiewicz, A. Li, P. McCue, L.N. Song, L. Tian, M. Jin, and R.G. Pestell The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth Cancer Res. 69 2009 3347 3355
34. M. Fu, C. Wang, J. Wang, X. Zhang, T. Sakamaki, Y.G. Yeung, C. Chang, T. Hopp, S.A. Fuqua, E. Jaffray, R.T. Hay, J.J. Palvimo, O.A. Janne, and R.G. Pestell Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function Mol. Cell. Biol. 22 2002 3373 3388
35. M. Fu, M. Rao, K. Wu, C. Wang, X. Zhang, M. Hessien, Y.G. Yeung, D. Gioeli, M.J. Weber, and R.G. Pestell The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity J. Biol. Chem. 279 2004 29436 29449
36. M. Fu, M. Rao, C. Wang, T. Sakamaki, J. Wang, D. Di Vizio, X. Zhang, C. Albanese, S. Balk, C. Chang, S. Fan, E. Rosen, J.J. Palvimo, O.A. Janne, S. Muratoglu, M.L. Avantaggiati, and R.G. Pestell Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth Mol. Cell. Biol. 23 2003 8563 8575
37. H. Dell, and M. Hadzopoulou-Cladaras CREB-binding protein is a transcriptional coactivator for hepatocyte nuclear factor-4 and enhances apolipoprotein gene expression J. Biol. Chem. 274 1999 9013 9021
38. R. Kurokawa, M. Soderstrom, A. Horlein, S. Halachmi, M. Brown, M.G. Rosenfeld, and C.K. Glass Polarity-specific activities of retinoic acid receptors determined by a corepressor Nature 377 1995 451 454
39. N.Y. Kalaany, and D.J. Mangelsdorf LXRS and FXR: the yin and yang of cholesterol and fat metabolism Annu. Rev. Physiol. 68 2006 159 191
40. N. Zelcer, C. Hong, R. Boyadjian, and P. Tontonoz LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor Science 325 2009 100 104
41. N. Zelcer, and P. Tontonoz Liver X receptors as integrators of metabolic and inflammatory signaling J. Clin. Invest. 116 2006 607 614
42. J.N. Feige, and J. Auwerx DisSIRTing on LXR and cholesterol metabolism Cell Metab. 6 2007 343 345
43. T. Claudel, B. Staels, and F. Kuipers The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism Arterioscler. Thromb. Vasc. Biol. 25 2005 2020 2030
44. C. Wang, M. Fu, S. Mani, S. Wadler, A.M. Senderowicz, and R.G. Pestell Histone acetylation and the cell-cycle in cancer Front. Biosci. 6 2001 D610 D629
45. L. Wang, L. Liu, and S.L. Berger Critical residues for histone acetylation by Gcn5 functioning in Ada and SAGA complexes, are also required for transcriptional function in vivo Genes Dev. 12 1998 640 653
46. J.L. Reid, A.J. Bannister, P. Zegerman, M.A. Martinez-Balbas, and T. Kouzarides E1A directly binds and regulates the P/CAF acetyltransferase EMBO J. 17 1998 4469 4477
47. A. Vassilev, Yanauchi, T. Kotani, C. Prives, M.L. Avantaggiati, J. Qi, and Y. Nakatani The 400 kDa subunit of the P/CAF histone acetylase complex belongs to the ATM superfamily Mol. Cell 2 1998 869 875
48. A.T. Reutens, M. Fu, G. Watanabe, C. Albanese, M.J. McPhaul, S.P. Balk, O.A. Janne, J.J. Palvimo, and R.G. Pestell Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner Mol. Endocrinol. 15 2001 797 811
49. T. Yamamoto, and M. Horikoshi Novel substrate specificity of the histone acetyltransferase activity of HIV-1-Tat interactive protein Tip60 J. Biol. Chem. 272 1997 30595 30598
50. M.E. Brady, D.M. Ozanne, L. Gaughan, I. Waite, S. Cook, D.E. Neal, and C.N. Robson Tip60 is a nuclear hormone receptor coactivator J. Biol. Chem. 274 1999 17599 17604
51. L. Gaughan, M.E. Brady, S. Cook, D.E. Neal, and C.N. Robson Tip60 is a coactivator specific for class I nuclear hormone receptors J. Biol. Chem. 276 2001 46841 46848
52. S. Bautista, H. Valles, R.L. Walker, S. Anzick, R. Zeillinger, P. Meltzer, and C. Theillet In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity Clin. Cancer Res. 4 1998 2925 2929
53. M.C. Louie, J.X. Zou, A. Rabinovich, and H.W. Chen ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance Mol. Cell. Biol. 24 2004 5157 5171
54. J.E. Herrera, K. Sakaguchi, M. Bergel, L. Trieschmann, Y. Nakatani, and M. Bustin Specific acetylation of chromosomal protein HMG-17 by PCAF alters its interaction with nucleosomes Mol. Cell. Biol. 19 1999 3466 3473
55. M.G. Lee, C. Wynder, N. Cooch, and R. Shiekhattar An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation Nature 437 2005 432 435
56. B.D. Strahl, and C.D. Allis The language of covalent histone modifications Nature 403 2000 41 45
57. W. Zhang, and J.J. Bieker Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases Proc. Natl. Acad. Sci. U.S.A. 95 1998 9855 9860
58. W. Gu, and R.G. Roeder Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain Cell 90 1997 595 606
59. J. Boyes, P. Byfield, Y. Nakatani, and V. Ogryzko Regulation of activity of the transcription factor GATA-1 by acetylation Nature 396 1998 594 598
60. T. Bouras, M. Fu, A.A. Sauve, F. Wang, A.A. Quong, N.D. Perkins, R.T. Hay, W. Gu, and R.G. Pestell SIRT1 deacetylation and repression of P300 involves lysine residues 1020/1024 within the cell-cycle regulatory domain 1 J. Biol. Chem. 280 2005 10264 10276
61. Y. Shang, X. Hu, J. DiRenzo, M.A. Lazar, and M. Brown Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription Cell 103 2000 843 852
62. H. Chen, R.J. Lin, W. Xie, D. Wilpitz, and R.M. Evans Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase Cell 98 1999 675 686
63. S.A. Fuqua, C. Wiltschke, Q.X. Zhang, A. Borg, C.G. Castles, W.E. Friedrichs, T. Hopp, S. Hilsenbeck, S. Mohsin, P. O'Connell, and D.C. Allred A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions Cancer Res. 60 2000 4026 4029
64. A. Villagra, F. Cheng, H.W. Wang, I. Suarez, M. Glozak, M. Maurin, D. Nguyen, K.L. Wright, P.W. Atadja, K. Bhalla, J. Pinilla-Ibarz, E. Seto, and E.M. Sotomayor The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance Nat. Immunol. 10 2009 92 100
65. L. Gao, M.A. Cueto, F. Asselbergs, and P. Atadja Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family J. Biol. Chem. 277 2002 25748 25755
66. M. Kruszewski, and I. Szumiel Sirtuins (histone deacetylases III) in the cellular response to DNA damage - facts and hypotheses DNA Repair (Amst.) 4 2005 1306 1313
67. H. Vaziri, S.K. Dessain, E. Ng Eaton, S.I. Imai, R.A. Frye, T.K. Pandita, L. Guarente, and R.A. Weinberg hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase Cell 107 2001 149 159
68. S. Nemoto, M.M. Fergusson, and T. Finkel SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha} J. Biol. Chem. 280 2005 16456 16460
69. F. Yeung, J.E. Hoberg, C.S. Ramsey, M.D. Keller, D.R. Jones, R.A. Frye, and M.W. Mayo Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase EMBO J. 23 2004 2369 2380
70. A. Van Der Horst, L.G. Tertoolen, L.M. De Vries-Smits, R.A. Frye, R.H. Medema, and B.M. Burgering FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2SIRT1 J. Biol. Chem. 2004
71. Y. Dai, D. Ngo, L.W. Forman, D.C. Qin, J. Jacob, and D.V. Faller Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor Mol. Endocrinol. 21 2007 1807 1821
72. M. Thomas, N. Dadgar, A. Aphale, J.M. Harrell, R. Kunkel, W.B. Pratt, and A.P. Lieberman Androgen receptor acetylation site mutations cause trafficking defects, misfolding, and aggregation similar to expanded glutamine tracts J. Biol. Chem. 279 2004 8389 8395
73. M. Fu, C. Wang, X. Zhang, and R.G. Pestell Acetylation of nuclear receptors in cellular growth and apoptosis Biochem. Pharmacol. 68 2004 1199 1208
74. M. Fu, M. Rao, T. Bouras, C. Wang, K. Wu, X. Jiao, X. Zhang, Z. Li, R.V. Rajnarayanan, N. Pattabiraman, T.-P. Yao, and R.G. Pestell Recruitment of HDACs by cyclin D1 inhibits PPAR-gamma mediated adipogenesis J. Biol. Chem. 279 2004 24745 24756
75. S. Sentis, M. Le Romancer, C. Bianchin, M.C. Rostan, and L. Corbo Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity Mol. Endocrinol. 19 2005 2671 2684
76. C.J. Sinal, M. Tohkin, M. Miyata, J.M. Ward, G. Lambert, and F.J. Gonzalez Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis Cell 102 2000 731 744
77. V. Duong, A. Licznar, R. Margueron, N. Boulle, M. Busson, M. Lacroix, B.S. Katzenellenbogen, V. Cavailles, and G. Lazennec ERalpha and ERbeta expression and transcriptional activity are differentially regulated by HDAC inhibitors Oncogene 25 2006 1799 1806
78. R. Margueron, V. Duong, S. Bonnet, A. Escande, F. Vignon, P. Balaguer, and V. Cavailles Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens J. Mol. Endocrinol. 32 2004 583 594
79. S.L. Anzick, J. Kononen, R.L. Walker, D.O. Azorsa, M.M. Tanner, X.Y. Guan, G. Sauter, O.P. Kallioniemi, J.M. Trent, and P.S. Meltzer AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer Science 277 1997 965 968
80. H.J. Zhou, J. Yan, W. Luo, G. Ayala, S.H. Lin, H. Erdem, M. Ittmann, S.Y. Tsai, and M.J. Tsai SRC3 is required for prostate cancer cell proliferation and survival Cancer Res. 65 2005 7976 7983
81. G. Zhou, Y. Hashimoto, I. Kwak, S.Y. Tsai, and M.J. Tsai Role of the steroid receptor coactivator SRC3 in cell growth Mol. Cell. Biol. 23 2003 7742 7755
82. V. Granados-Soto Pleiotropic effects of resveratrol Drug News Perspect. 16 2003 299 307
83. K.T. Howitz, K.J. Bitterman, H.Y. Cohen, D.W. Lamming, S. Lavu, J.G. Wood, R.E. Zipkin, P. Chung, A. Kisielewski, L.L. Zhang, B. Scherer, and D.A. Sinclair Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191 196
84. J.N. Lin, V.C. Lin, K.M. Rau, P.C. Shieh, D.H. Kuo, J.C. Shieh, W.J. Chen, S.C. Tsai, and T.D. Way Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation J. Agric. Food Chem. 58 2010 1584 1592
85. M. Lagouge, C. Argmann, Z. Gerhart-Hines, H. Meziane, C. Lerin, F. Daussin, N. Messadeq, J. Milne, P. Lambert, P. Elliott, B. Geny, M. Laakso, P. Puigserver, and J. Auwerx Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha Cell 127 2006 1109 1122
86. L. Le Corre, N. Chalabi, L. Delort, Y.J. Bignon, and D.J. Bernard-Gallon Resveratrol and breast cancer chemoprevention: molecular mechanisms Mol. Nutr. Food Res. 49 2005 462 471
87. J.L. Bowers, V.V. Tyulmenkov, S.C. Jernigan, and C.M. Klinge Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta Endocrinology 141 2000 3657 3667
88. K.P. Bhat, D. Lantvit, K. Christov, R.G. Mehta, R.C. Moon, and J.M. Pezzuto Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models Cancer Res. 61 2001 7456 7463
89. A.P. Dennis, and B.W. O'Malley Rush hour at the promoter: how the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription J. Steroid Biochem. Mol. Biol. 93 2005 139 151
90. A.P. Dennis, D.M. Lonard, Z. Nawaz, and B.W. O'Malley Inhibition of the 26S proteasome blocks progesterone receptor-dependent transcription through failed recruitment of RNA polymerase II J. Steroid Biochem. Mol. Biol. 94 2005 337 346